Carl Johan Kördel
Vorstandsvorsitzender bei Chori Pars AB
Ursprung des Netzwerks ersten Grades von Carl Johan Kördel
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Lund
290
| College/University | Other Consumer Services | 290 |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA.
13
| Extinct | Biotechnology | 13 |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden.
12
| Extinct | Miscellaneous Commercial Services | 12 |
| Subsidiary | Pharmaceuticals: Other | 10 | |
| Public Company | Pharmaceuticals: Major | 10 | |
| Public Company | Pharmaceuticals: Generic | 9 | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm.
8
| Private Company | Investment Managers | 8 |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Lundbeckfonden Ventures
 Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark.
5
| Operating Division | Investment Managers | 5 |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA.
3
| Holding Company | Pharmaceuticals: Major | 3 |
River Vision Development Corp.
 River Vision Development Corp. BiotechnologyHealth Technology River Vision Development Corp. develops novel protein therapies. The firm provides therapy for the treatment of graves orbitopathy which is a condition in which an autoimmune response is mounted against tissues behind the eye, causing inflammation, tissue proliferation and excess production of extracellular matrix. The company was founded in 2011 and is headquartered in New York, NY.
2
| Subsidiary | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Carl Johan Kördel
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| LIFEASSAYS AB (PUBL) | Medical Specialties | Director/Board Member Chief Executive Officer Director/Board Member | |
| GENOVIS AB | Medical Specialties | Director/Board Member Chief Executive Officer Chairman | |
| BTG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Chairman | |
| ANOTO GROUP AB | Computer Peripherals | Chief Executive Officer Sales & Marketing | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Stockholm School of Economics | College/University | Undergraduate Degree Director/Board Member Masters Business Admin Undergraduate Degree | |
| University of Uppsala | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| University of Stockholm | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of Nottingham | College/University | Undergraduate Degree Doctorate Degree | |
Skandinaviska Enskilda Banken AB (Broker)
 Skandinaviska Enskilda Banken AB (Broker) Investment Banks/BrokersFinance Skandinaviska Enskilda Banken AB (Broker) (SEB-Broker) is the broker/dealer division of Skandinaviska Enskilda Banken AB (STO: SEB-A; OTCMKTS: SVKEF), a financial group headquartered in Stockholm, Sweden. Founded in 1856, SEB-Broker provides trading and executions services to their clients. | Investment Banks/Brokers | Market Strategist Analyst-Fixed Income | |
| CAMURUS AB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree Corporate Officer/Principal Graduate Degree | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director/Board Member | |
| University of Gothenburg | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Investment Managers | Private Equity Investor Chief Executive Officer Private Equity Investor | |
| Faculty of Engineering, Lund University | College/University | Graduate Degree Director/Board Member | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Connect Sverige Region Syd
 Connect Sverige Region Syd Investment ManagersFinance Connect Sverige Region Syd operates as a non-profit organization that offers financial advices and entrepreneurial support. The company was founded in 1999 and is headquartered in Lund, Sweden. | Investment Managers | Public Communications Contact Chairman | |
| GASPOROX AB | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Create Health | Director/Board Member Corporate Officer/Principal | ||
| IMMUNOVIA AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
Oncorel AB
 Oncorel AB Miscellaneous Commercial ServicesCommercial Services Oncorel AB provides medical research services. It pertains to develop anti-cancer treatment. The company was founded in 2009 and is headquartered in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| NEOS AB | Medical Specialties | Director/Board Member Director/Board Member | |
Medicon Valley Alliance FMBA
 Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Medicon Valley Alliance FMBA operates a life science cluster that spans across Denmark and Sweden. The non-profit company is based in the Medicon Valley region. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| INHALATION SCIENCES SWEDEN AB | Medical Specialties | Director of Finance/CFO Director of Finance/CFO | |
| ACOUSORT AB | Medical Distributors | Director/Board Member Chairman | |
Swednano Tech AB
 Swednano Tech AB Financial ConglomeratesFinance Swednano Tech AB provides financial support services. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member Director/Board Member | |
BioActive Polymers in Lund AB
 BioActive Polymers in Lund AB BiotechnologyHealth Technology BioActive Polymers in Lund AB operates as bio-surgery focused company that offers product for abdominal and pelvic surgery. It develops BioBarrier, a post-surgical adhesion barrier spray. The firm's product is formulated to seek out and visibly self-bond specifically to the desired wound sites, perform its barrier function, and resorb. The company was founded by Gert Roland Andersson, Stig Bengmark, Björn Lindman, and Kåre Larsson in 1999 and is headquartered in Lund, Sweden. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| ACUCORT AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| LUMITO AB | Medical Specialties | Founder Director/Board Member | |
| GABATHER AB | Pharmaceuticals: Major | Chairman Founder | |
| GeccoDots AB | Director/Board Member Chairman | ||
Cell Therapy Catapult Ltd.
 Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
| HAMLET PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Director/Board Member | |
Reccan Diagnostics AB
 Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Reccan Diagnostics AB provides cancer diagnosis and treatment. It offers tumor specific diagnosis, prognosis, prediction, and treatment selection with tumor specific directed therapy; and provides tumor-specific biomarkers for diagnosis and treatment selection. The company was founded by Gyorgy Marko-Varga, Roland Andersson, and Daniel Ansari and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member Founder | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Camurus Development AB | Chairman Director/Board Member | ||
| Nanoecho AB | Director/Board Member Chairman | ||
| SELECTIMMUNE PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
umanSense AB
 umanSense AB Packaged SoftwareTechnology Services umanSense AB develops smart mobile software applications for medical and healthcare services. The company was founded by Johan Wasselius, Cecilia Belfrage and Petter Ericson and is headquartered in Lund, Sweden. | Packaged Software | Chairman Director/Board Member | |
| AMNIOTICS AB | Biotechnology | Chairman Director/Board Member | |
| Betagenon Bio AB | Director/Board Member Chairman | ||
Reccan AB
 Reccan AB Medical SpecialtiesHealth Technology Reccan AB is a company headquartered in Lund, Sweden. The firm develops blood tests for pancreatic cancer diagnosis. It was founded in 2014 by György Marko-Varga and Roland Andersson. Malin Bornschein is the current CEO of the firm. | Medical Specialties | Director/Board Member Founder | |
Amplifier TX AB
 Amplifier TX AB BiotechnologyHealth Technology Part of Cambrian BioPharma, Inc., Amplifier TX AB is a Swedish biopharmaceutical company that develops clinical molecule AMPK activators. The private company is based in Umeå, Sweden. The company was founded in 2023 by Thomas Edlund, Helena Edlund. James Hall has been the CEO of the company since 2023. | Biotechnology | Director/Board Member Chief Executive Officer |
Statistik
International
| Schweden | 45 |
| Vereinigtes Königreich | 4 |
| Dänemark | 3 |
| Vereinigte Staaten | 2 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 8 |
| Commercial Services | 7 |
| Finance | 5 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 562 |
| Corporate Officer/Principal | 203 |
| Chairman | 150 |
| Founder | 87 |
| Independent Dir/Board Member | 84 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Carl Johan Kördel
- Unternehmensverbindungen
